Melanoma Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Melanoma Epidemiology Forecast Report Coverage

Expert Market Research's “Melanoma Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of melanoma. It projects the future incidence and prevalence rates of melanoma cases across various populations. The study covers age, gender, and type as major determinants of the melanoma population. The report highlights patterns in the prevalence of melanoma over time and projects future trends based on multiple variables.

Melanoma Understanding: Disease Overview

Melanoma is a type of skin cancer that occurs in melanocytes, the cells that produce melanin (the pigment that gives skin its color). It is mostly brought on by prolonged exposure to ultraviolet (UV) radiation from tanning beds or the sun, which damages skin cells' DNA. If melanoma is not discovered in time, it may spread to other areas of the body and manifest as an odd mole or dark patch. Fair skin, a history of sunburns, a genetic susceptibility, and a compromised immune system are risk factors.

Melanoma Epidemiology Perspective

The melanoma epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for melanoma epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for melanoma and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• The American Cancer Society projects that 104,960 new cases of melanoma will be detected in the United States in 2025 (about 60,550 in males and 44,410 in women). Furthermore, it is anticipated that 8,430 people including 5,470 men and 2,960 women will die from melanoma.
• According to a study, since the early 2000s, the prevalence rates of melanoma have decreased by roughly 1% annually for men and remained constant for women under 50. Rates for women aged 50 and over have risen by almost 3% year, while rates for males have remained constant.
• Another study revealed, as people age, their risk of developing melanoma rises. People are typically 66 years old when they receive a diagnosis. However, even in people under 30, melanoma is not unusual.
• As per statistics, white people have a 3% (1 in 33) lifetime risk of developing melanoma, black people have a 0.1% (1 in 1,000) risk, and hispanic people have a 0.5% (1 in 200) risk.

Read more about this report - Request a Free Sample

Country-wise Melanoma Epidemiology

The melanoma epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of melanoma varies between countries owing to the differences in factors such as UV exposure, increased cosmetic procedures and others. According to the Melanoma Foundation, melanoma is the second most prevalent malignancy among people aged 15 to 29. It is believed that indoor tanning and UV damage from childhood sunburns are to blame for the high rate in this young group. Around 200,340 new instances of melanoma (99,700 benign and 100,640 invasive) were diagnosed in 2024, and 7,990 people died from the condition. Approx 300 children and young adults under the age of 19 in the United States receive a melanoma diagnosis each year.

Key Questions Answered

• What are the key findings of melanoma epidemiology in the 8 major markets?
• What will be the total number of patients with melanoma across the 8 major markets during the forecast period?
• What was the country-wise melanoma epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of melanoma patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of melanoma during the forecast period of 2026-2035?
• What are the currently available treatments for melanoma?
• What are the disease risks, signs, symptoms, and unmet needs of melanoma?

Scope of the Melanoma Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of melanoma based on several factors.
• Melanoma Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The melanoma report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Global Dermal Facial Fillers Market

Global Dermatology Laser Market